Biotechnology, defense, infrastructure, Onshoring, Quality, small caps, US
The fund underperformed the Russell 2000 Index despite strong showings from healthcare and semiconductor holdings like Ligand and Materion. Management cited tariff uncertainty, rate cuts, and supply chain reshoring as major macro factors shaping small-cap performance. The team remains optimistic on domestic small caps, citing secular tailwinds from infrastructure spending, technology innovation, and reshoring trends.
This report provides a detailed summary of investor holdings for a
specified stock ticker, highlighting key metrics such as fund
name, total assets under management (AUM), invested value,
portfolio weight, and shares owned. It also tracks changes in
share ownership during the last quarter, including the percentage
of shares bought or sold and the percentage of outstanding shares
owned. The data is generated using an API that processes investor
holdings and calculates these values for each fund. This report
helps investors and analysts monitor the stock positions of major
funds, identify investment trends, and assess the influence of
large investors on individual stocks.
